Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity - Stock Options (Details)

v3.21.1
Stockholders’ Equity - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Number of Shares    
Outstanding (in shares) 3,919,550  
Granted (in shares) 66,300  
Forfeited (in shares) (64,925)  
Outstanding (in shares) 3,920,925 3,919,550
Exercisable (in shares) 1,723,350  
Weighted Average Exercise Price    
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 4.47  
Granted (in dollars per share) 9.74  
Forfeited (in dollars per share) 4.37  
Outstanding, Weighted Average Exercise Price (in dollars per share) 4.56 $ 4.47
Exercisable (in dollars per share) $ 2.98  
Outstanding, Weighted Average Remaining Life (Year) 7 years 10 months 28 days 8 years 1 month 9 days
Exercisable, Weighted Average Remaining Life (Year) 7 years 5 months 4 days  
Outstanding, Aggregate Intrinsic Value $ 47,601 $ 13,095
Exercisable, Aggregate Intrinsic Value $ 23,642